ZA935718B - Liponucleotides of seco-nucleosides and pharmaceutical compositions with antiviral action containing them - Google Patents

Liponucleotides of seco-nucleosides and pharmaceutical compositions with antiviral action containing them

Info

Publication number
ZA935718B
ZA935718B ZA935718A ZA935718A ZA935718B ZA 935718 B ZA935718 B ZA 935718B ZA 935718 A ZA935718 A ZA 935718A ZA 935718 A ZA935718 A ZA 935718A ZA 935718 B ZA935718 B ZA 935718B
Authority
ZA
South Africa
Prior art keywords
seco
nucleosides
liponucleotides
pharmaceutical compositions
antiviral action
Prior art date
Application number
ZA935718A
Inventor
Harald Zilch
Dieter Hermmann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of ZA935718B publication Critical patent/ZA935718B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention concerns phospholipid derivatives of seco-nucleosides, in which a lipid with a substituted three-carbon-atom basic structure is linked to a seco-nucleoside via a phosphate or thiophosphate group. The invention also concerns the use of such derivatives as anti-viral drugs.
ZA935718A 1992-08-08 1993-08-06 Liponucleotides of seco-nucleosides and pharmaceutical compositions with antiviral action containing them ZA935718B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4226279A DE4226279A1 (en) 1992-08-08 1992-08-08 Lipo nucleotides of seco-nucleosides, their production and their use as antiviral drugs

Publications (1)

Publication Number Publication Date
ZA935718B true ZA935718B (en) 1995-02-06

Family

ID=6465143

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935718A ZA935718B (en) 1992-08-08 1993-08-06 Liponucleotides of seco-nucleosides and pharmaceutical compositions with antiviral action containing them

Country Status (20)

Country Link
EP (1) EP0654036B1 (en)
JP (1) JP3479299B2 (en)
KR (1) KR100243440B1 (en)
CN (1) CN1040984C (en)
AT (1) ATE152114T1 (en)
AU (1) AU672994B2 (en)
CA (1) CA2141030A1 (en)
DE (2) DE4226279A1 (en)
DK (1) DK0654036T3 (en)
ES (1) ES2104163T3 (en)
FI (1) FI109699B (en)
GR (1) GR3023960T3 (en)
HU (1) HUT72605A (en)
IL (1) IL106588A (en)
MX (1) MX9304676A (en)
NO (1) NO304986B1 (en)
NZ (1) NZ254813A (en)
TW (1) TW306924B (en)
WO (1) WO1994003465A1 (en)
ZA (1) ZA935718B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
DE4402492A1 (en) * 1994-01-28 1995-08-03 Boehringer Mannheim Gmbh Process for the production of asymmetrical phosphoric acid diesters
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
KR100389558B1 (en) * 2000-10-11 2003-06-27 주식회사 한스환경엔지니어링 Surface Treating Fabric For FRP

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
DE4026265A1 (en) * 1990-08-20 1992-02-27 Boehringer Mannheim Gmbh NEW PHOSPHOLIPID DERIVATIVES OF NUCLEOSIDES, THEIR PRODUCTION AND THEIR USE AS ANTIVIRAL MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
KR950702998A (en) 1995-08-23
DE4226279A1 (en) 1994-02-10
ATE152114T1 (en) 1997-05-15
IL106588A (en) 1998-01-04
WO1994003465A1 (en) 1994-02-17
EP0654036B1 (en) 1997-04-23
KR100243440B1 (en) 2000-03-02
DE59306286D1 (en) 1997-05-28
FI950533A0 (en) 1995-02-07
HUT72605A (en) 1996-05-28
JPH08500345A (en) 1996-01-16
NO950445L (en) 1995-02-07
AU4708293A (en) 1994-03-03
MX9304676A (en) 1994-03-31
NZ254813A (en) 1996-05-28
GR3023960T3 (en) 1997-09-30
DK0654036T3 (en) 1997-11-03
JP3479299B2 (en) 2003-12-15
IL106588A0 (en) 1993-12-08
HU9500374D0 (en) 1995-03-28
ES2104163T3 (en) 1997-10-01
FI109699B (en) 2002-09-30
EP0654036A1 (en) 1995-05-24
NO950445D0 (en) 1995-02-07
AU672994B2 (en) 1996-10-24
CA2141030A1 (en) 1994-02-09
TW306924B (en) 1997-06-01
CN1040984C (en) 1998-12-02
CN1085908A (en) 1994-04-27
NO304986B1 (en) 1999-03-15
FI950533A (en) 1995-02-07

Similar Documents

Publication Publication Date Title
MX9202851A (en) PHOSPHATE DERIVATIVES OF 4-DESMETILEPIPODOFILOTOXINA GLUCOSIDES AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM.
IL105727A (en) 7-(2-mercapto-acetamido)-octahydro-6-oxopyrido[2,1-a][2]-benzazepine derivatives analogs thereof their preparation and pharmaceutical enkephalinase-inhibiting compositions containing them
AU627845B2 (en) Improvements in or relating to devices for administration of drugs or the like
AU1779488A (en) Polysaccharides and antiviral drugs containing the same as active ingredient
PL261349A1 (en) Method of obtaining an incorporative complex of 7-isopropoxyisoflavone with cyclodextrin
GB8501015D0 (en) Drug
FI945363A (en) Novel mercaptoacetylamidopyridazo (1,2) pyridazine, pyrazolo (1,2) pyridazine, pyridazo (1,2-a) (1,2) diazepine and pyrazolo (1,2-a) (1,2) diazepine derivatives, which are useful as inhibitors of encephalase and ACE
CA2133177A1 (en) Rapamycin formulations for oral administration
IL88765A0 (en) Adenosine derivatives and pharmaceutical compositions containing them
JO1502B1 (en) Novel pharmacological compounds
ES2033426T3 (en) PROCEDURE FOR THE PREPARATION OF CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS CONTAINING 3'-AZIDO-3'-DEOXYTIMIDINE.
CA2085354A1 (en) Ether lipid-nucleoside covalent conjugates
NZ222716A (en) A lipid composition comprising 97% by weight or greater of phosphatidylcholine
IL87800A (en) Carboxy (alkyl) dioxolane, dithiolane and oxothiolane derivatives and pharmaceutical compositions comprising them
ZA935718B (en) Liponucleotides of seco-nucleosides and pharmaceutical compositions with antiviral action containing them
ES8207184A1 (en) Pharmaceutical composition for oral administration containing cytidine diphosphocholine
NZ222741A (en) Pharmaceutical compositions containing an interferon and a purine derivative
ES8705763A1 (en) Pharmaceutical compositions containing gels.
MY119473A (en) Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
SV1996000001A (en) NEW LISOZYME DIMER APPLICATIONS
ES8607217A1 (en) Improvements in or relating to anticonvulsant agents.
JPS6416890A (en) Antioxidant
AU549428B3 (en) Improvements in/or relating to the stability of light weight display items
ES2032209T3 (en) DERIVATIVES OF PROTEINS THAT CONTAIN IRON IN A HIGHLY BIOAVAILABLE FORM, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
EP0210703A3 (en) Acylphosphorotriamides useful as lipid-altering agents